malondialdehyde has been researched along with holothurin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Ding, Y; Li, Y; Wang, M; Wen, A | 1 |
| Ahmad, W; Al-Harrasi, A; Csuk, R; Halim, SA; Karim, N; Khan, A; Khan, I; Khan, M; Rehman, NU | 1 |
2 other study(ies) available for malondialdehyde and holothurin a
| Article | Year |
|---|---|
Posttreatment with 11-Keto-β-Boswellic Acid Ameliorates Cerebral Ischemia-Reperfusion Injury: Nrf2/HO-1 Pathway as a Potential Mechanism.
Topics: Animals; Antioxidants; Apoptosis; Astrocytes; Boswellia; Brain; Brain Damage, Chronic; Cell Hypoxia; Cells, Cultured; Drug Evaluation, Preclinical; Glucose; Heme Oxygenase (Decyclizing); Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Nerve Tissue Proteins; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Phytotherapy; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Superoxide Dismutase; Triterpenes | 2015 |
Anti-diabetic potential of β-boswellic acid and 11-keto-β-boswellic acid: Mechanistic insights from computational and biochemical approaches.
Topics: Animals; Blood Glucose; Boswellia; Diabetes Mellitus, Experimental; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Lipids; Malondialdehyde; Plant Extracts; Random Allocation; Rats; Rats, Sprague-Dawley; Streptozocin; Superoxide Dismutase; Triterpenes; Weight Loss | 2022 |